AMAG Pharmaceuticals, Inc. AMAG Income Statement

Amag pharmaceuticals, inc. (AMAG)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Revenue from Contract with Customer [Abstract]
Revenues:
Revenues
320,608	327,751	326,167	364,274	432,419	474,002	510,210	518,343	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	455,123	-	399,156	372,296	353,965	341,816	297,966	232,058	169,890	109,998	82,363	76,810	0	-	0	0	-	-	-	-	-	-	0	0	0	-	47,703	32,530	0	0	0
Service revenues, net
-	-	-	-	-	-	-	-	-	-	-	-	107,015	-	79,041	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other revenues
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License fee, collaboration and other revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,261	1,279	40,454	52,328	57,651	60,078	23,164	14,386	11,223	10,736	10,473	9,164	12,620	12,188	26,725	26,475	21,910	22,051	7,747	8,321	8,006	8,828	0	-	0	0	-	-	0
U.S. Feraheme product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Other product sales and royalties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	907	626	814	616	0	0	0	-	-	-	-	-	-	-	-	-	-
Royalties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	130	150	0	0	0
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	562,263	-	489,236	441,606	438,071	418,276	362,794	292,136	193,054	124,384	92,842	88,964	83,811	80,856	80,289	76,415	87,778	85,378	79,141	78,954	63,344	61,249	63,562	62,899	66,324	66,245	52,046	35,209	0	0	0
Costs and expenses:
Cost of product sales
113,075	107,193	92,587	117,971	170,457	215,892	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of product sales
-	-	-	-	-	-	-	-	-	-	-	-	105,587	-	84,659	78,041	75,783	78,509	71,551	55,431	38,495	20,306	11,874	11,453	11,855	11,960	12,661	14,437	14,516	14,220	12,932	11,278	10,136	10,531	10,230	9,835	9,637	7,606	5,296	3,022	0	0	0
Cost of services
-	-	-	-	-	-	-	-	-	-	-	-	20,059	-	18,966	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development expenses
57,967	64,853	60,587	55,390	52,103	44,846	44,631	50,772	69,337	75,017	83,003	83,845	67,821	65,561	53,476	56,169	50,119	42,878	42,745	28,294	24,650	24,160	22,977	22,149	21,658	20,564	21,886	22,616	26,238	33,296	38,378	48,012	57,036	58,140	58,434	57,571	55,660	54,462	47,292	43,375	0	0	0
Acquired in-process research and development
0	74,856	74,856	87,356	87,356	32,500	32,500	20,000	25,845	65,845	65,845	65,845	60,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative expenses
264,615	286,600	283,756	290,487	229,061	227,810	198,645	138,156	181,158	178,151	138,439	183,693	176,717	169,468	222,570	211,495	191,372	160,309	137,575	102,392	86,875	72,254	59,750	63,726	62,653	59,167	56,779	54,005	53,895	53,071	55,615	60,685	62,410	68,863	73,183	73,939	81,117	84,939	84,797	84,079	0	0	0
Impairment of Intangible Assets, Finite-lived
-	-	0	0	-	-	0	0	-	-	0	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition-related costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring expenses
20	7,420	7,400	7,400	7,400	0	0	0	0	-	-	-	-	341	3,095	3,833	4,187	4,136	0	0	0	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Total costs and expenses
667,993	773,258	596,564	635,982	546,397	521,048	528,533	765,527	788,264	799,608	716,359	442,814	425,052	347,408	402,278	394,793	348,211	307,056	277,621	201,285	162,092	128,221	97,300	98,110	96,948	92,473	91,921	92,215	96,864	102,802	112,053	124,541	133,090	141,042	144,071	143,569	148,638	149,231	137,385	130,476	0	0	0
Operating loss
-347,385	-445,507	-270,397	-271,708	-113,978	-47,046	-41,059	-275,960	-314,580	-303,839	-270,199	22,797	37,607	85,079	86,958	46,813	89,860	111,220	85,173	90,851	30,962	-3,837	-858	-7,907	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income (expense):
Interest expense
25,863	25,709	25,771	32,718	42,444	51,971	61,378	64,859	66,059	68,382	70,554	72,016	73,010	73,153	73,459	69,372	61,327	53,251	41,835	30,742	23,588	14,697	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-	-	0	-	-	-	0	-	-	-	0	0	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and dividend income
3,176	4,285	5,771	6,543	6,271	5,328	3,836	2,711	2,422	2,810	3,011	3,362	3,472	3,149	2,864	2,550	2,149	1,512	1,133	900	781	975	1,087	1,042	1,045	1,051	1,033	1,082	1,164	1,286	1,383	1,466	1,580	1,747	1,808	1,878	1,830	1,741	1,826	2,161	0	0	0
Gains on marketable securities, net
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gains on investments, net
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
1,399	428	286	312	266	-74	-63	-113	0	-	0	0	-	189	-8,986	-8,960	0	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other (expense) income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-70,407	-86,241	-78,595	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gains on sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gains (losses) on investments, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38	-1,437	0	-	0	0	-	-193	-188	-598	405	408	83	754	0	0	0
Fair value adjustment of settlement rights
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Total other expense, net
-21,288	-20,996	-19,451	-61,785	-71,829	-82,639	-94,651	-63,630	-74,660	-76,568	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0	-	1,937	1,984	3	-180	-85	10	1,386	1,554	1,620	1,280	1,447	1,361	1,442	2,263	0	0	0
Loss before income taxes
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from continuing operations before income taxes
-	-	-289,848	-333,493	-	-129,685	-135,710	-339,590	-389,240	-380,407	-347,621	-55,446	-31,935	15,264	16,551	-39,428	11,265	39,844	24,940	61,112	8,272	-17,342	0	0	0	-	-	-	-	-	0	0	-	-	0	0	-	-81,625	-83,897	-93,004	0	0	0
Income tax expense (benefit)
190	-47	-2,537	-5,137	47,563	39,700	11,462	-101,335	-162,594	-175,300	-135,087	-14,821	-4,966	13,200	1,277	-17,922	-1,083	7,065	0	0	0	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	0	0	-	-	0
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
-	-	-287,273	-328,334	-	-169,339	-304,307	-253,881	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax
-	-	-1	5,837	-	18,873	23,380	17,915	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of CBR business
-	-	0	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense
-	-	-974	-1,072	-	2,371	4,199	4,484	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent
-	-	-1,532	93,985	-	103,578	108,762	13,431	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-368,863	-466,456	-288,805	-234,349	-133,603	-65,761	-40,025	-222,925	-216,910	-199,228	-213,243	-44,986	-31,516	-2,483	15,274	-21,506	12,348	32,779	168,586	190,628	155,823	135,817	-10,845	-12,448	-12,809	-9,602	-9,634	-13,456	-8,229	-16,750	-31,645	-44,309	-67,190	-77,069	-75,484	-80,177	0	-	0	0	-	0	0
Total (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-0.30	0.47	-0.02	-0.22	0.10	-0.62	1.09	0.47	6.39	0.07	-0.07	-0.33	-	-0.01	-	-	-	-	0.16	-	-	-	-0.92	-	-	-	-	-1.15	-1.29	-1.55
Total (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-0.26	0.43	-0.02	-0.22	0.34	-0.62	0.82	0.39	5.79	0.06	-0.07	-0.33	-	-0.01	-	-	-	-	0.15	-	-	-	-0.92	-	-	-	-	-1.15	-1.29	-1.55
Loss from continuing operations (in dollars per share)
-	-	-0.70	-3.57	-	-0.59	-1.88	-0.75	-1.70	-	-4.41	-0.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.09	-0.18	-	-0.19	-	-0.58	-	-0.78	-	-1.05	-	-0.81	-	-	-	-
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share
-	-	0.00	0.00	-	-0.04	2.77	0.17	0.11	-	0.10	0.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted net loss per share (in dollars per share)
-0.72	-5.90	-0.70	-3.57	-3.54	-0.63	0.89	-0.58	-1.59	0.06	-4.31	-0.40	-1.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.01	-	-	-
Weighted Average Number of Shares Outstanding, Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	34,251	34,171	34,223	34,739	34,812	33,223	30,636	27,213	23,931	21,984	21,925	21,824	-	21,691	-	-	-	-	21,370	-	-	-	21,167	21,144	-	21,085	21,017	19,985	17,117	17,038
Weighted average shares outstanding used to compute net loss per share (basic and diluted) (in shares)
34,104	-	33,906	33,807	34,469	-	34,492	34,358	34,162	-	35,311	35,145	34,378	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21,603	21,544	-	21,403	-	21,349	-	21,194	-	-	-	-	-	-	-	-
Weighted Average Number of Shares Outstanding, Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	28,259	42,111	34,223	34,739	26,583	33,223	43,181	38,245	33,684	23,467	21,925	21,824	-	21,691	-	-	-	-	21,649	-	-	-	21,167	21,144	-	21,085	21,017	19,985	17,117	17,038
Product Sales
Revenues
304,089	311,190	325,859	363,990	432,233	473,852	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other revenues
Revenues
119	161	308	284	186	150	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-